Phase 1 β Early testing in a small group of people (usually 20β80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
China
Beijing GoBroad Hospital, Beijing, Beijing Municipality ζΉζ±δΈεΏδΊΊζ°ε»ι’, Zhanjiang, Guangdong Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality Shanghai Liquan Hospital, Shanghai, Shanghai Municipality